The impact of alcohol and interferon treatment on the clinical outcome of hepatitis C (HCV)-related cirrhosis

被引：0
|
作者：
Jamal, MM
Vega, KJ
Rabaa, E
Johnston, DE
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
530
引用
收藏
页码：A647 / A647
页数：1
相关论文
共 50 条
  • [41] HEPATITIS-C VIRUS (HCV) GENOTYPES AND CLINICAL COURSE OF ANTI-HCV POSITIVE CIRRHOSIS
    BENVEGNU, L
    PONTISSO, P
    CAVALLETTO, D
    CHEMELLO, L
    ALBERTI, A
    HEPATOLOGY, 1995, 22 (04) : 945 - 945
  • [42] Determinants of outcome of compensated hepatitis C virus-related cirrhosis
    Serfaty, L
    Aumaître, H
    Chazouillères, O
    Bonnand, AM
    Rosmorduc, O
    Poupon, RE
    Poupon, R
    HEPATOLOGY, 1998, 27 (05) : 1435 - 1440
  • [43] Efficacy and tolerability of pegylated interferon and ribavirin in patients with hepatitis C related cirrhosis
    Macesic, N.
    Ratnam, D.
    Pianko, S.
    Dev, A.
    Sievert, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A281 - A282
  • [44] Safety of interferon β treatment for chronic HCV hepatitis
    Festi, D
    Sandri, L
    Mazzella, G
    Roda, E
    Sacco, T
    Staniscia, T
    Capodicasa, S
    Vestito, A
    Colecchia, A
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (01) : 12 - 16
  • [45] Safety of interferon β treatment for chronic HCV hepatitis
    DFesti
    LSandri
    GMazzella
    ERoda
    AColecchia
    TSacco
    TStaniscia
    SCapodicasa
    AVestito
    World Journal of Gastroenterology, 2004, (01) : 12 - 16
  • [46] Underestimated impact of alcohol consumption on the progression of fibrosis in patients transplanted for HCV-related cirrhosis: A comparative study with transplanted for alcohol-related cirrhosis
    Sobesky, R
    Francoz, C
    Paradis, V
    Belghiti, J
    Valla, D
    Marcellin, P
    Durand, F
    LIVER TRANSPLANTATION, 2006, 12 (05) : C113 - C113
  • [47] Response to pegylated interferon-ribavirin in patients with recurrent hepatitis C in patients undergoing liver transplantation for mixed (alcohol-HCV) cirrhosis
    Aguilera, V.
    Berenguer, M.
    Palau, A.
    Rubin, A.
    Aguas, M.
    Benlloch, S.
    Prieto, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S62 - S62
  • [48] Efficacy of interferon alone or ribavirin interferon combination in HCV related cirrhosis and chronic hepatitis patients: A randomized controlled trial.
    Sarin, SK
    Guptan, RC
    Thakur, V
    HEPATOLOGY, 1999, 30 (04) : 634A - 634A
  • [49] Hydroxychloroquine reduces liver related mortality in hepatitis C associated (HCV) compensated cirrhosis
    Kouroumalis, EA
    Moschandreas, J
    Alexandrakis, G
    Matrella, E
    GUT, 2002, 50 : A114 - A115
  • [50] Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C
    Morisco, F
    Mazziotti, G
    Rotondi, M
    Tuccillo, C
    Iasevoli, P
    Del Buono, A
    Sorvillo, F
    Amato, G
    Marmo, R
    Caporaso, N
    Carella, C
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (03) : 247 - 253
12345